rs864622513

Variant summary

Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM1BP4_StrongBP6BS2

The NM_001492.6(GDF1):​c.925T>C​(p.Ser309Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000114 in 1,461,894 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S309S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00011 ( 2 hom. )

Consequence

GDF1
NM_001492.6 missense

Scores

3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.728
Variant links:
Genes affected
GDF1 (HGNC:4214): (growth differentiation factor 1) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. Studies in rodents suggest that this protein is involved in the establishment of left-right asymmetry in early embryogenesis and in neural development in later embryogenesis. The encoded protein is translated from a bicistronic mRNA that also encodes ceramide synthase 1. Mutations in this gene are associated with several congenital cardiovascular malformations. [provided by RefSeq, Jul 2016]
CERS1 (HGNC:14253): (ceramide synthase 1) This gene encodes a ceramide synthase enzyme, which catalyzes the synthesis of ceramide, the hydrophobic moiety of sphingolipids. The encoded enzyme synthesizes 18-carbon (C18) ceramide in brain neurons. Elevated expression of this gene may be associated with increased longevity, while decreased expression of this gene may be associated with myoclonus epilepsy with dementia in human patients. This protein is transcribed from a monocistronic mRNA as well as a bicistronic mRNA, which also encodes growth differentiation factor 1. [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -7 ACMG points.

PM1
In a disulfide_bond (size 70) in uniprot entity GDF1_HUMAN there are 5 pathogenic changes around while only 1 benign (83%) in NM_001492.6
BP4
Computational evidence support a benign effect (MetaRNN=0.035881877).
BP6
Variant 19-18868791-A-G is Benign according to our data. Variant chr19-18868791-A-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 220404.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1, Likely_benign=1}.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GDF1NM_001492.6 linkuse as main transcriptc.925T>C p.Ser309Pro missense_variant 8/8 ENST00000247005.8
CERS1NM_021267.5 linkuse as main transcriptc.*1194T>C 3_prime_UTR_variant 8/8 ENST00000623882.4
GDF1NM_001387438.1 linkuse as main transcriptc.925T>C p.Ser309Pro missense_variant 5/5
CERS1NM_001387440.1 linkuse as main transcriptc.*1786T>C 3_prime_UTR_variant 7/7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GDF1ENST00000247005.8 linkuse as main transcriptc.925T>C p.Ser309Pro missense_variant 8/81 NM_001492.6 P1
CERS1ENST00000623882.4 linkuse as main transcriptc.*1194T>C 3_prime_UTR_variant 8/81 NM_021267.5 P2P27544-1

Frequencies

GnomAD3 genomes
AF:
0.000127
AC:
19
AN:
149084
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00113
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000975
GnomAD3 exomes
AF:
0.00106
AC:
118
AN:
111764
Hom.:
1
AF XY:
0.000603
AC XY:
37
AN XY:
61390
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00566
Gnomad ASJ exome
AF:
0.000137
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000315
GnomAD4 exome
AF:
0.000112
AC:
147
AN:
1312702
Hom.:
2
Cov.:
31
AF XY:
0.0000849
AC XY:
55
AN XY:
647564
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00464
Gnomad4 ASJ exome
AF:
0.0000463
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000764
GnomAD4 genome
AF:
0.000127
AC:
19
AN:
149192
Hom.:
0
Cov.:
33
AF XY:
0.0000686
AC XY:
5
AN XY:
72852
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00113
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.000964
Alfa
AF:
0.000131
Hom.:
0
Bravo
AF:
0.000298

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

GDF1-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesNov 27, 2023The GDF1 c.925T>C variant is predicted to result in the amino acid substitution p.Ser309Pro. This variant, which was reported as p.S56P, has previously been identified in one individual with tetralogy of Fallot, aortic root dilation, and pulmonary valve stenosis and functional studies in zebrafish found a reduction in TGFβ signaling compared to controls (Karkera et al. 2007. PubMed ID: 17924340). This variant is reported in 0.57% of alleles in individuals of Latino descent in gnomAD; however, quality metrics at this site indicates the frequency estimate may not be reliable. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 18, 2023- -
Progressive myoclonic epilepsy type 8 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeOct 15, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.048
BayesDel_addAF
Benign
-0.27
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
6.1
DANN
Benign
0.46
DEOGEN2
Uncertain
0.54
D;.
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.29
T;.
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.036
T;T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
-0.46
N;.
MutationTaster
Benign
0.99
N;N
PROVEAN
Benign
-2.0
N;.
REVEL
Uncertain
0.53
Sift
Benign
0.25
T;.
Sift4G
Benign
0.31
T;T
Vest4
0.65
MutPred
0.80
Loss of catalytic residue at S309 (P = 0.0214);Loss of catalytic residue at S309 (P = 0.0214);
MVP
0.47
MPC
1.2
ClinPred
0.021
T
GERP RS
0.87
Varity_R
0.18
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs864622513; hg19: chr19-18979600; API